These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11742248)

  • 1. Defective Fas ligand production in lymphocytes from MS patients.
    Macchi B; Matteucci C; Nocentini U; Tacconi S; Pagnini V; Mastino A; Caltagirone C
    Neuroreport; 2001 Dec; 12(18):4113-6. PubMed ID: 11742248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of clinical activity in relapsing-remitting MS is associated with a decrease of FasL mRNA and an increase of Fas mRNA in peripheral blood.
    Lopatinskaya L; van Boxel-Dezaire AH; Barkhof F; Polman CH; Lucas CJ; Nagelkerken L
    J Neuroimmunol; 2003 May; 138(1-2):123-31. PubMed ID: 12742662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of immunoregulatory T-helper cell subsets in patients with multiple sclerosis: relapsing-progressive course correlates with enhanced T H1, relapsing-remitting course with enhanced T H0 reactivity.
    Barth H; Klein K; Börtlein A; Guseo A; Berg PA; Wiethölter H; Klein R
    J Neuroimmunol; 2002 Dec; 133(1-2):175-83. PubMed ID: 12446020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediators of apoptosis Fas and FasL predict disability progression in multiple sclerosis over a period of 10 years.
    Lopatinskaya L; Zwemmer J; Uitdehaag B; Lucas K; Polman C; Nagelkerken L
    Mult Scler; 2006 Dec; 12(6):704-9. PubMed ID: 17262997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy.
    Martínez-Rodríguez JE; Saez-Borderías A; Munteis E; Romo N; Roquer J; López-Botet M
    Clin Immunol; 2010 Oct; 137(1):41-50. PubMed ID: 20580616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
    J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CD40L expression on T CD4+ lymphocytes from peripheral blood in patients with relapsing-remitting and secondary progressive multiple sclerosis].
    Bilińska M; Frydecka I; Kosmaczewska A; Ciszak L; Koszewicz M; Pokryszko-Dragan A
    Pol Merkur Lekarski; 2006 Jan; 20(115):41-5. PubMed ID: 16617733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Fas antigen on T cell subpopulations in peripheral blood of patients with relapsing-remitting multiple sclerosis.
    Bilińska M; Frydecka I; Podemski R; Teodorowska R; Gruszka E
    Med Sci Monit; 2001; 7(2):251-5. PubMed ID: 11257731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis.
    Jensen J; Krakauer M; Sellebjerg F
    Eur J Neurol; 2001 Jul; 8(4):321-8. PubMed ID: 11422428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
    Lutterotti A; Kuenz B; Gredler V; Khalil M; Ehling R; Gneiss C; Egg R; Deisenhammer F; Berger T; Reindl M
    J Neuroimmunol; 2006 Dec; 181(1-2):145-9. PubMed ID: 17046070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes.
    Alatab S; Maghbooli Z; Hossein-Nezhad A; Khosrofar M; Mokhtari F
    Minerva Med; 2011 Dec; 102(6):461-8. PubMed ID: 22193377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective regulation of IFNgamma and IL-12 by endogenous IL-10 in progressive MS.
    Balashov KE; Comabella M; Ohashi T; Khoury SJ; Weiner HL
    Neurology; 2000 Jul; 55(2):192-8. PubMed ID: 10908889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fas receptor expression on peripheral blood T lymphocytes in patients with secondary progressive multiple sclerosis].
    Bilińska M; Frydecka I; Podemski R
    Pol Merkur Lekarski; 2003 May; 14(83):421-4. PubMed ID: 12939817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
    Vogt MH; Lopatinskaya L; Smits M; Polman CH; Nagelkerken L
    Ann Neurol; 2003 Jun; 53(6):819-22. PubMed ID: 12783433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis.
    Sharief MK; Semra YK
    J Neuroimmunol; 2001 Oct; 119(2):358-64. PubMed ID: 11585640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating CD8+CD56-perforin+ T cells are increased in multiple sclerosis patients.
    Giovanni F; Domenico P; Alessandro M; Raffaele I; Viviana N; Katia PA; Paola BA
    J Neuroimmunol; 2011 Dec; 240-241():137-41. PubMed ID: 22001684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis.
    Rolland A; Jouvin-Marche E; Saresella M; Ferrante P; Cavaretta R; Créange A; Marche P; Perron H
    J Neuroimmunol; 2005 Mar; 160(1-2):195-203. PubMed ID: 15710473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century.
    Pinti M; Troiano L; Nasi M; Bellodi C; Ferraresi R; Mussi C; Salvioli G; Cossarizza A
    Circulation; 2004 Nov; 110(19):3108-14. PubMed ID: 15505087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis.
    Durán I; Martínez-Cáceres EM; Brieva L; Tintoré M; Montalban X
    Mult Scler; 2001 Jun; 7(3):151-6. PubMed ID: 11475437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon gamma production in blood lymphocytes correlates with disability score in multiple sclerosis patients.
    Petereit HF; Richter N; Pukrop R; Bamborschke S
    Mult Scler; 2000 Feb; 6(1):19-23. PubMed ID: 10694841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.